196 related articles for article (PubMed ID: 27322785)
1. TTF-1 and PAX5 Are Frequently Expressed in Combined Merkel Cell Carcinoma.
Czapiewski P; Majewska H; Kutzner H; Kazakov D; Renkielska A; Biernat W
Am J Dermatopathol; 2016 Jul; 38(7):513-6. PubMed ID: 27322785
[TBL] [Abstract][Full Text] [Related]
2. Histogenesis of pure and combined Merkel cell carcinomas: An immunohistochemical study of 14 cases.
Narisawa Y; Koba S; Inoue T; Nagase K
J Dermatol; 2015 May; 42(5):445-52. PubMed ID: 25720654
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.
Pulitzer MP; Brannon AR; Berger MF; Louis P; Scott SN; Jungbluth AA; Coit DG; Brownell I; Busam KJ
Mod Pathol; 2015 Aug; 28(8):1023-32. PubMed ID: 26022453
[TBL] [Abstract][Full Text] [Related]
4. Dermal and Intraepidermal Merkel Cell Carcinoma With Squamous Cell Carcinoma: A Report of a Rare Case With Special Reference to the Touch Dome.
Narisawa Y; Inoue T; Nagase K
Am J Dermatopathol; 2021 Jan; 43(1):15-20. PubMed ID: 32000217
[TBL] [Abstract][Full Text] [Related]
5. Oral cavity neuroendocrine carcinoma: a comparison study with cutaneous Merkel cell carcinoma and other mucosal head and neck neuroendocrine carcinomas.
Lewis JS; Duncavage E; Klonowski PW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):209-17. PubMed ID: 20659699
[TBL] [Abstract][Full Text] [Related]
6. A case of intraepidermal Merkel cell carcinoma within squamous cell carcinoma in-situ: Merkel cell carcinoma in-situ?
Al-Ahmadie HA; Mutasim DF; Mutema GK
Am J Dermatopathol; 2004 Jun; 26(3):230-3. PubMed ID: 15166513
[TBL] [Abstract][Full Text] [Related]
7. Letter to the Editor: Diffuse TTF-1 expression in a case of Merkel cell carcinoma.
Iliadis A; Koletsa T; Kostopoulos I; Tzioufa V
Pol J Pathol; 2015 Jun; 66(2):200-1. PubMed ID: 26247534
[No Abstract] [Full Text] [Related]
8. Immunohistochemical profiles of different subsets of Merkel cell carcinoma.
Pasternak S; Carter MD; Ly TY; Doucette S; Walsh NM
Hum Pathol; 2018 Dec; 82():232-238. PubMed ID: 30067951
[TBL] [Abstract][Full Text] [Related]
9. Divergent differentiation in endocrine and nonendocrine tumors of the skin.
Foschini MP; Eusebi V
Semin Diagn Pathol; 2000 May; 17(2):162-8. PubMed ID: 10839616
[TBL] [Abstract][Full Text] [Related]
10. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
Cho WC; Vanderbeck K; Nagarajan P; Milton DR; Gill P; Wang WL; Curry JL; Torres-Cabala CA; Ivan D; Prieto VG; Aung PP
Arch Pathol Lab Med; 2023 Jul; 147(7):758-766. PubMed ID: 36745184
[TBL] [Abstract][Full Text] [Related]
11. CD117, CK20, TTF-1, and DNA topoisomerase II-alpha antigen expression in small cell tumors.
Yang DT; Holden JA; Florell SR
J Cutan Pathol; 2004 Mar; 31(3):254-61. PubMed ID: 14984578
[TBL] [Abstract][Full Text] [Related]
12. INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma.
Lilo MT; Chen Y; LeBlanc RE
Am J Surg Pathol; 2018 Nov; 42(11):1541-1548. PubMed ID: 30080705
[TBL] [Abstract][Full Text] [Related]
13. Triple collision tumor comprising Merkel cell carcinoma with an unusual immunophenotype, squamous cell carcinoma in situ, and basal cell carcinoma.
Hobbs MM; Geers TE; Brown TS; Malone JC
J Cutan Pathol; 2020 Aug; 47(8):764-767. PubMed ID: 32243639
[TBL] [Abstract][Full Text] [Related]
14. Squamous Cell Carcinoma In Situ Overlying Merkel Cell Carcinoma.
McGowan MA; Helm MF; Tarbox MB
J Cutan Med Surg; 2016 Nov; 20(6):563-566. PubMed ID: 27207346
[TBL] [Abstract][Full Text] [Related]
15. Loss of cytokeratin 20 and acquisition of thyroid transcription factor-1 expression in a merkel cell carcinoma metastasis to the brain.
Shalin SC; Cifarelli CP; Suen JY; Gao L
Am J Dermatopathol; 2014 Nov; 36(11):904-6. PubMed ID: 24901475
[TBL] [Abstract][Full Text] [Related]
16. Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapy.
Kurzen H; Kaul S; Egner U; Deichmann M; Hartschuh W
Arch Dermatol Res; 2003 Aug; 295(4):146-54. PubMed ID: 12844224
[TBL] [Abstract][Full Text] [Related]
17. Frequent expression of glypican-3 in Merkel cell carcinoma: an immunohistochemical study of 55 cases.
He H; Fang W; Liu X; Weiss LM; Chu PG
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):40-6. PubMed ID: 18813128
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma: squamous and atypical fibroxanthoma-like differentiation in successive local tumor recurrences.
Boutilier R; Desormeau L; Cragg F; Roberts P; Walsh N
Am J Dermatopathol; 2001 Feb; 23(1):46-9. PubMed ID: 11176052
[TBL] [Abstract][Full Text] [Related]
19. LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers.
Sundqvist B; Sihto H; von Willebrand M; Böhling T; Koljonen V
Virchows Arch; 2021 Dec; 479(6):1197-1207. PubMed ID: 34331569
[TBL] [Abstract][Full Text] [Related]
20. Intraepidermal and dermal Merkel cell carcinoma with squamous cell carcinoma in situ: a case report with review of literature.
Sirikanjanapong S; Melamed J; Patel RR
J Cutan Pathol; 2010 Aug; 37(8):881-5. PubMed ID: 19702685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
